相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 5-HT4 Receptor Agonist Prucalopride Stimulates Mucosal Growth and Enhances Carbohydrate Absorption in the Ileum of the Mouse
Christine J. Park et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2019)
Intraluminal prucalopride increases propulsive motor activities via luminal 5-HT4 receptors in the rabbit colon
Mitra Shokrollahi et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Luminal 5-HT4 receptors-A successful target for prokinetic actions
Rachel M. Gwynne et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Colonic Motility and Jejunal Vagal Afferent Firing Rates Are Decreased in Aged Adult Male Mice and Can Be Restored by an Aminosterol
Christine L. West et al.
FRONTIERS IN NEUROSCIENCE (2019)
Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion
Yogesh Bhattarai et al.
CELL HOST & MICROBE (2018)
Altered gastrointestinal motility involving autoantibodies in the experimental autoimmune encephalomyelitis model of multiple sclerosis
E. T. Spear et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
YH12852, a potent and highly selective 5-HT4 receptor agonist, significantly improves both upper and lower gastrointestinal motility in a guinea pig model of postoperative ileus
Z. Hussain et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents
Hong Yang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Chronic constipation
Michael Camilleri et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride
J. Tack et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Impaired colonic motility and reduction in tachykinin signalling in the aged mouse
Bhavik Anil Patel et al.
EXPERIMENTAL GERONTOLOGY (2014)
Effect of prucalopride on symptoms of chronic constipation
J. Tack et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
Gary M. Mawe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders
J. Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Activation of Colonic Mucosal 5-HT4 Receptors Accelerates Propulsive Motility and Inhibits Visceral Hypersensitivity
Jill M. Hoffman et al.
GASTROENTEROLOGY (2012)
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
J. Tack et al.
GUT (2009)
Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation:: A randomized controlled trial
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
5-HT4 receptor agonists:: similar but not the same
J. H. De Maeyer et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Safety and tolerability of tegaserod in patients with chronic constipation: Pooled data from two phase III studies
Eamonn M. M. Quigley et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT4 agonist tegaserod
JR Grider
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Expression and function of 5-HT4 receptors in the mouse enteric nervous system
M Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays
JY Jin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Signalling mechanism coupled to 5-hydroxytryptamine4 receptor-mediated facilitation of fast synaptic transmission in the guinea-pig ileum myenteric plexus
JJ Galligan et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2003)
Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome
G Tougas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
分享论文
